Cite
MLA Citation
Zhongnan Xu et al.. “A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects.” Expert opinion on investigational drugs, vol. 31, 2022, pp. 737–746. http://access.bl.uk/ark:/81055/vdc_100159167644.0x000024